Cardiovascular Devices Often Approved by FDA Without High-quality Studies, Study Says

by Rajshri on  December 30, 2009 at 8:34 PM Medico Legal News
  •   Print
  •   Share
  •   Comments
  •  Text 
 Cardiovascular Devices Often Approved by FDA Without High-quality Studies, Study Says
A study in the December 23/30 issue of JAMA says that pre-market approval by the FDA of cardiovascular devices is often based on studies that lack adequate strength or may have been prone to bias.

The researchers found that of nearly 80 high-risk devices, the majority received approval based on data from a single study.

Cardiovascular devices are increasing in number and usage. "In 2008, at least 350,000 pacemakers, 140,000 implantable cardioverter-defibrillators, and 1,230,000 stents were implanted. Although there has been recent scrutiny of evidence used in the U.S. Food and Drug Administration (FDA) drug approval process, less attention has been paid to the approval process for medical devices," the authors write. They add that the study data on which FDA approval is based should be of high quality. "Ideally, this evidence should consist of randomized, double-blinded studies with adequate controls, sufficient duration, and thorough follow-up on prespecified primary end points without bias."

Sanket S. Dhruva, M.D., of the University of California, San Francisco, and colleagues analyzed the type and quality of study evidence used by the FDA for the premarket approval (PMA) of cardiovascular devices. These types of devices were included in the study because it was expected they would undergo the most stringent approval process, given their increasing usage and potential impact on illness and risk of death. The authors conducted a systematic review of 123 summaries of safety and effectiveness data (SSEDs) for 78 PMAs for high-risk cardiovascular devices that received PMA between January 2000 and December 2007, examining the methodological characteristics and primary end points. SSEDs are intended to present a reasoned, objective, and balanced critique of the scientific evidence which served as the basis of the decision to approve or deny the PMA.

Page 1 Page 1 | 2  Next
 Email Email   RSS Feeds RSS Feeds   Print this page Print   Save this page Save   Link Link   Syndicate Syndicate   Comments Comments   Bookmark and Share
 
Comment & Contribute
Comments should be on the topic and should not be abusive. Comments are normally moderated and are reviewed after they are posted.
* Your comment can be maximum of 2500 characters

Notify me when reply is posted
I agree to the terms and conditions
  
If you have a question about health related issues, you can now post it in our Ask An Expert section on our community website Medwonders.com and get answers from our panel of experts.
X

Medwonders Health Network

  • Health News Index
A B C D E F G H I J K L M N O P Q R S T U V W X Y Z
News Archive
Date :
Category :
Keyword :
  • News Quick Links
News Central Health Watch
Latest Health News Health In Focus
News Category (500+) Breaking Health News
Popular News Celebrating Life
Health News and Press Release Medindia - Exclusive
News Photo Gallery India Special
News Video Gallery Lifestyle and Wellness
News From Other Resources
News Categories:  
Teen's Health Center

Medico Legal Related News

» Australia Says Plain Cigarette Packaging is Anti-Cancer and Not Anti-Trade » Smoking Ban in Public Places Sees Drop in Number of Smokers by Five Percent
» Chinese Patient to Get 60,000 Yuan Compensation from Hospital After Swallowing Doctor’s Syringe » Tobacco Companies Challenging New Packaging Rules Made to Wait by Australian Court
» Notice Issued by Supreme Court on Sterilization » Diet Guru Pierre Dukan Targeted by French Medical Orders
» Blood Monitoring Patents Rejected » Judge Bans Woman from Having Sex
Read More >>